BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 11/11/22

BlackRock Science and Technology Trust II ( NYSE: BSTZ ) had declared $0.192/share monthly dividend , in line with previous. Payable Nov. 30; for shareholders of record Nov. 15; ex-div Nov. 14. See BSTZ Dividend Scorecard, Yield Chart, & Dividend Growth. ...

Summary The volatility had continued since earlier this year when we last looked at my top ten CEFs. With closed-end fund discounts widening, there seem to be more opportunities in the space overall. Regardless of how the remainder of the year shakes out, my income has continu...

While vanilla investors worry along with the herd, we contrarians are buying. And oh, the yields we have available! As I write to you today, I’m staring at no less than 29 income funds that yield more than 8% . Twenty-nine paying more than eight! For retirees with a milli...

Summary BSTZ yields 12.69%. It's very beaten down, and sells at a 17.54% discount to NAV. We compare BSTZ to its sister fund, BST. If you're looking for a long term contrarian income investment, you may want to consider BlackRock Science and Technology Trust II ( B...

BlackRock Advisors, LLC released today share repurchase activity for certain BlackRock closed-end funds (the “Funds”) during the quarter ended September 30, 2022. The Funds have authorized open market share repurchase programs (the “Repurchase Programs”) purs...

Summary BSTZ is a technology equities CEF with a global allocation mandate. The CEF is a micro-universe of the 2021 excesses and is currently pummeled as liquidity is drained from speculative assets. With 4% Treasury rates, the cost of opportunity is very different than in yea...

BlackRock Advisors, LLC announced today that the Boards of Directors/Trustees of fifty BlackRock municipal, taxable fixed income, equity, and multi-asset closed-end funds (the “Funds”) have authorized the renewal of open market share repurchase programs (the “Repurc...

Summary NBXG launched at a poor time for the growth-oriented investments that they target. The poor results and the fund being new have contributed to a significantly wide discount. The fund's distribution would seem to be at risk, barring any sharp snapback. Written b...

BlackRock today announced the release of quarterly fund commentaries for BlackRock Innovation and Growth Trust (NYSE: BIGZ), BlackRock Science and Technology Trust II (NYSE: BSTZ), BlackRock Health Sciences Trust II (NYSE: BMEZ), BlackRock Capital Allocation Trust (NYSE: BCAT), and Blac...

It's been a stellar month+ for the more aggressive and leveraged equity CEFs with the more defensive option-income CEFs having more mixed results. Generally speaking, option-income CEFs that sell a low percentage of options against their portfolio have performed better than option fun...